NRx Pharmaceuticals, Inc. announced the date for its 2025 Annual Meeting and Record Date.
The meeting will be held on March 23, 2026, at 10:00 a.m. Eastern Time in a virtual-only format.
Stockholders of record as of February 12, 2026, will be entitled to notice of and vote at the 2025 Annual Meeting.
Annual Meeting Details
The 2025 Annual Meeting will take place on March 23, 2026, and will be conducted virtually.
Record Date
Stockholders as of February 12, 2026, are eligible to receive meeting notifications and vote at the annual meeting.
Submission Deadline
Stockholder proposals must be submitted by January 26, 2026, for consideration at the 2025 Annual Meeting.
Proxy Statement
The Company will provide additional details in its proxy statement to be filed with the SEC prior to the meeting.
- The announcement provides clarity to stockholders regarding important dates and procedures for the upcoming annual meeting.
- The virtual format allows for broader participation from shareholders regardless of their location.
- Setting the record date ensures that stockholders have sufficient time to prepare for the meeting and exercise their voting rights.
NRx Pharmaceuticals' proactive announcement of the annual meeting date and record date demonstrates transparency and commitment to engaging with shareholders. The provided information equips stockholders with essential details to participate effectively in the upcoming meeting.